When to cut the cord: Moving on from your CMO Partner as a research based biotech

When to cut the cord: Moving on from your CMO Partner as a research based biotech

We were delighted to welcome Jan Gustafsson, Operations and External Partnerships Manager, Phico Therapeutics Ltd. to the Pharma Contract and Manufacturing conference, which took place last March in London. In this session he presented his expert insights into the "cutting the cord" - Moving on from your CMO Partner as a research based biotech. 

What you will discover from this presentation 

  • Understanding the biggest differences in CMO relationship paradigms between Big Pharma, Biotechs and research stage Biotechs
  • Identifying the warning signs that should encourage you to review whether you outsource or in-house manufacture
  • Creating a strategy to transition from outsourced manufacturing to in-house manufacturing that minimises production downtime and process disruption

If you like what you see, download the full presentation here by clicking download >> 


Please note: That all fields marked with an asterisk (*) are required.